Abstract
Purpose
Currently, no reliable data are available concerning the type and frequency of symptoms in premenopausal women with uterine myomas.
Methods
2296 women were examined by means of vaginal ultrasound for the presence of myomas in seven gynaecological outpatient departments in Germany. From this population, 1314 premenopausal women between the ages of 30 and 55 years were evaluated to determine the type and frequency of myoma-related symptoms and their relationship to anamnestic factors, and the number, size, and location of the myomas. Standardised questionnaires were used to record the symptoms.
Results
Prevalence: In almost every second premenopausal woman (n = 639; 48.6%), uterine myomas were diagnosed. The frequency of myomas increased continuously with age and was highest in women between 46 and 50 years (65.2%). Age itself was found to be the main risk factor for the presence of myomas (p < 0.001). Symptoms: 54.3% (n = 347) of the women suffered from myoma-related symptoms. The four main symptoms were identified as: Heavy menstrual bleeding (40.7%), dysmenorrhoea (28.2%), lower abdominal pain (14.9%), and intermenstrual bleeding (14.1%). In the majority of cases, the symptoms occurred simultaneously. Determinants for symptoms: Symptoms did not follow a clear age-related trend, whilst the number and size of the myomas did determine the presence of symptoms. The main influencing factor for the presence of intermenstrual bleeding was the location of the myomas.
Conclusions
The high prevalence of uterine myomas highlights the importance of the diagnosis uterine myomas in standard gynaecological practice: The presence of only one myoma caused symptoms in 46.5% and small myomas of up to 2 cm in diameter resulted in symptoms in 39.5%.
Similar content being viewed by others
References
Ahrendt HJ, Tylkoski H, Rabe T, Szczes A, Friedrich C, Roehl FW, Kitay A, Roemer T, Foth D (2016) Prevalence of uterine myomas in women in Germany: data of an epidemiological study. Arch Gynecol Obstet 293:1243–1253
Commandeur AE, Styer AK, Teixeira JM (2015) Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth. Hum Reprod Update 21:593–615
Khan AT, Shehmar M, Gupta JK (2014) Uterine fibroids: current perspectives. Int J Womens Health 6:95–114
Segars JH, Parrott EC, Nagel JD, Guo XC, Gao X, Birnbaum LS, Pinn VW, Dixon D (2014) Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations. Hum Reprod Update 20:309–333
Yan L, Ding L, Li C, Wang Y, Tang R, Chen ZJ (2014) Effect of fibroids not distorting the endometrial cavity on the outcome of in vitro fertilization treatment: a retrospective cohort study. Fertil Steril 101:716–721
Borah BJ, Nicholson WK, Bradley L, Stewart EA (2013) The impact of uterine leiomyomas: a national survey of affected women. Am J Obstet Gynecol 209:319.e1–319.e20
Marret H, Fauconnier A, Chabbert-Buffet N et al (2010) Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause. Eur J Obstet Gynecol Reprod Biol 152:133–137
Van Voorhis B (2009) A 41-year-old woman with menorrhagia, anemia, and fibroids: review of treatment of uterine fibroids. JAMA 301:82–93
Lerner D, Mirza FG, Chang H, Renzulli K, Perch K, Chelmow D (2008) Impaired work performance among women with symptomatic uterine fibroids. J Occup Environ Med 50(10):1149–1157. doi:10.1097/JOM.0b013e3181895e10
Collins J, Crosignani PG (2007) Endometrial bleeding. Hum Reprod Update 13:421–431
Parker WH (2007) Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril 87:725–736
Drayer SM, Catherino WH (2015) Prevalence, morbidity, and current medical management of uterine leiomyomas. Int J Gynaecol Obstet 131:117–122
Fraser IS, Critchley HO, Broder M, Munro MG (2011) The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med 29:383–390
Munro MG, Critchley HO, Fraser IS, FIGO Menstrual Disorders Working Group (2011) The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil Steril 95:2204–2208
Marshall LM, Spiegelman D, Barbieri RL, Goldman MB, Manson JE, Colditz GA, Willett WC, Hunter DJ (1997) Variation in the incidence of uterine leiomyoma among pre-menopausal women by age and race. Obstet Gynecol 90:967–973
Borgfeldt C, Andolf E (2000) Transvaginal ultrasonographic findings in the uterus and Endometrium: low prevalence of leiomyoma in a random sample of women age 25–40 years. Acta Obstet Gynecol Scand 79:202–207
Marsh EE, Ekpo GE, Cardozo ER, Brocks M, Dune T, Cohen LS (2013) Racial differences in fibroid prevalence and ultrasound findings in asymptomatic young women (18–30 years old): a pilot study. Fertil Steril 99:1951–1957
Lurie S, Piper I, Woliowitch I, Glezerman M (2005) Age-related prevalence of sonographicaly confirmed uterine myomas. J Obstet Gynaecol 25:42–43
Marino JL, Eskenazi B, Warner M, Samuels S, Vercellini P, Gavoni N, Olive D (2004) Uterine leiomyoma and menstrual cycle characteristics in a population-based cohort study. Hum Reprod 19:2350–2355
ESHRE Capri Workshop Group, Collins J, Crosignani PG (2007) Endometrial bleeding. Hum Reprod Update 13:421–431
Zimmermann A, Bernuit D, Gerlinger C, Schaefers M, Geppert K (2012) Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC Womens Health. doi:10.1186/1472-6874-12-6
Wegienka G, Baird DD, Hertz-Picciotto I, Harlow SD, Steege JF, Hill MC, Schectman JM, Hartmann KE (2003) Self-reported heavy bleeding associated with uterine leiomyomata. Obstet Gynecol 101:431–437
El-Nashar SA, Shazly SAM, Famuyide AO (2015) Pictorial blood loss assessment chart for quantification of menstrual blood loss: a systematic review. Gynecol Surg 12:157–163
Prütz F, Knopf H, von der Lippe E, Scheidt-Nave C, Starker A, Fuchs J (2013) Prevalence of Hysterectomy in women 18 to 79 years old. Results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsbl 56:716–722
Ferrero S, Abbamonte LH, Giordano M, Parisi M, Ragni N, Remorgida V (2006) Uterine myomas, dyspareunia, and sexual function. Fertil Steril 86:1504–1510
Lippman SA, Warner M, Samuels S, Olive D, Vercellini P, Eskenazi B (2003) Uterine fibroids and gynecologic pain symptoms in a population-based study. Fertil Steril 80:1488–1494
Ekin M, Cengiz H, Öztürk E, Kaya C, Yasar L, Savan K (2014) Genitourinary symptoms and their effects on quality of life in women with uterine myomas. Int Urogynecol J 25:807–810
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest. The data were collected between 01/12/2011 and 31/03/2013 in seven representative gynaecological practice offices in Germany: Ahrendt, Magdeburg; Tylkoski, Magdeburg; Friedrich, Köthen; Szczes, Braunschweig; Lesny, Hamburg; Reindl, Magdeburg; and Schmidt-Pich and Partner, Hannover.
Ethical standards
The study has been approved by the appropriate ethics committee (Ethics Committee of Saxony-Anhalt) and has, therefore, been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All persons gave their informed consent prior to their inclusion in the study.
Additional information
In memory of Prof. Hans-Joachim Ahrendt.
Rights and permissions
About this article
Cite this article
Foth, D., Röhl, FW., Friedrich, C. et al. Symptoms of uterine myomas: data of an epidemiological study in Germany. Arch Gynecol Obstet 295, 415–426 (2017). https://doi.org/10.1007/s00404-016-4239-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-016-4239-y